TDMS Study 96007-01 Pathology Tables
NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08
LAB: Battelle Columbus TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126) DATE: 10/01/03
EXPERIMENT: 96007 TEST: 01 TIME: 12:18:02
TEST TYPE: CHRONIC CAGES FROM 0000 TO LAST CAGE PAGE: 1
CONT: N01-ES-75411 ROUTE: GAVAGE NTP C#: 96007D
PATHOLOGIST: MISSING CAS: 57465-28-8
------------------------------------------------------------------------------------------------------------------------------------
FINAL #3/CONTROL VS. TREATED
REASONS FOR REMOVAL: 25022 Accidently Killed
25018 Dosing Accident
25019 Moribund Sacrifice
25020 Natural Death
25021 Terminal Sacrifice
REMOVAL DATE RANGE: ALL
TREATMENT GROUPS: INCLUDE 001 0 NG/KG
INCLUDE 003 30 NG/KG
INCLUDE 004 100 NG/KG
INCLUDE 005 175 NG/KG
INCLUDE 006 300 NG/KG
INCLUDE 007 550 NG/KG
INCLUDE 008 1000 NG/KG
NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08
LAB: Battelle Columbus TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126) DATE: 10/01/03
EXPERIMENT: 96007 TEST: 01 TIME: 12:18:02
TEST TYPE: CHRONIC CAGES FROM 0000 TO LAST CAGE
CONT: N01-ES-75411 ROUTE: GAVAGE NTP C#: 96007D
PATHOLOGIST: MISSING CAS: 57465-28-8
Rats(SPRAGUE-DAWLEY)
-----------------------------
FOR ALL DOSES THE TUMOR RATES IN THE FOLLOWING TISSUES/ORGANS ARE
BASED ON NUMBER OF TISSUES EXAMINED. IN OTHER TISSUES/ORGANS RATES
ARE BASED ON THE NUMBER OF ANIMALS NECROPSIED.
---------------
Adrenal Cortex
Adrenal Medulla
Brain
Heart
Islets, Pancreatic
Kidney
Liver
Lung
Ovary
Pancreas
Parathyroid Gland
Pituitary Gland
Salivary Glands
Thyroid Gland
NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08
LAB: Battelle Columbus TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126) DATE: 10/01/03
EXPERIMENT: 96007 TEST: 01 TIME: 12:18:02
TEST TYPE: CHRONIC CAGES FROM 0000 TO LAST CAGE
CONT: N01-ES-75411 ROUTE: GAVAGE NTP C#: 96007D
PATHOLOGIST: MISSING CAS: 57465-28-8
SUMMARY OF STATISTICALLY SIGNIFICANT (P<=.05) RESULTS
IN THE ANALYSIS OF TOXIC EQUIVALENCY FACTOR EVALUATION (
===============================================================
Female Rats
------------
Organ Morphology
----- ----------
Adrenal Cortex Adenoma
Adrenal Medulla Pheochromocytoma Benign
Pheochromocytoma: Benign, Complex, Malignant, NOS
Brain Astrocytoma Malignant
Oligodendroglioma, Glioma, or Astrocytoma
Liver Cholangiocarcinoma
Hepatocellular Adenoma
Hepatocellular Carcinoma or Hepatocellular Adenoma
Hepatocellular Carcinoma, Hepatocellular Adenoma, or Hepatoblastoma
Hepatocholangioma
Lung Cystic Keratinizing Epithelioma
Squamous Cell Carcinoma
Mammary Gland Carcinoma
Carcinoma or Adenoma
Fibroadenoma
Fibroma, Fibroadenoma or Adenoma
Fibroma, Fibroadenoma, Carcinoma, or Adenoma
Oral Cavity (Oral Mucosa, Tongue, Pharynx, Tooth, Gingiva)
Squamous Cell Carcinoma
Squamous Cell Carcinoma, Papilloma Squamous, or Papilloma
Oral Mucosa Squamous Cell Carcinoma
Pituitary Gland: Pars Distalis or Unspecified Site
Adenoma
Carcinoma or Adenoma
Thyroid Gland: C-Cell Adenoma
All Organs Hemangiosarcoma
Benign Tumors
Malignant Tumors
Malignant and Benign Tumors
===============================================================
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 1
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Adrenal Cortex |
| Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 0/52 (0%) 1/55 (2%) 1/53 (2%) 0/53 (0%) 0/53 (0%) 1/52 (2%) 2/53 (4%) |
|POLY-3 RATE (b) | 0/31.36 1/38.53 1/39.60 0/37.32 0/36.61 1/41.55 2/32.75 |
|POLY-3 PERCENT (g) | 0.0% 2.6% 2.5% 0.0% 0.0% 2.4% 6.1% |
|TERMINAL (d) | 0/15 (0%) 1/25 (4%) 1/26 (4%) 0/22 (0%) 0/16 (0%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | --- 727 (T) 727 (T) --- --- 722 603 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.041 * P=0.602 P=0.610 (e) (e) P=0.602 P=0.276 |
|POLY 3 | P=0.103 P=0.541 P=0.546 (e) (e) P=0.555 P=0.245 |
|POLY 1.5 | P=0.105 P=0.527 P=0.531 (e) (e) P=0.536 P=0.247 |
|POLY 6 | P=0.107 P=0.561 P=0.565 (e) (e) P=0.576 P=0.233 |
|LOGISTIC REGRESSION| P=0.087 P=0.602 P=0.610 (e) (e) P=0.609 P=0.243 |
|COCH-ARM / FISHERS | P=0.105 P=0.514 P=0.505 (e) (e) P=0.500 P=0.252 |
|ORDER RESTRICTED | P=0.080 (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Adrenal Cortex |
| Carcinoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 0/52 (0%) 1/55 (2%) 0/53 (0%) 0/53 (0%) 1/53 (2%) 0/52 (0%) 2/53 (4%) |
|POLY-3 RATE (b) | 0/31.36 1/38.53 0/39.60 0/37.32 1/37.02 0/41.53 2/32.51 |
|POLY-3 PERCENT (g) | 0.0% 2.6% 0.0% 0.0% 2.7% 0.0% 6.2% |
|TERMINAL (d) | 0/15 (0%) 1/25 (4%) 0/26 (0%) 0/22 (0%) 0/16 (0%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | --- 727 (T) --- --- 607 --- 588 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.054 P=0.602 (e) (e) P=0.561 (e) P=0.229 |
|POLY 3 | P=0.097 P=0.541 (e) (e) P=0.533 (e) P=0.243 |
|POLY 1.5 | P=0.094 P=0.527 (e) (e) P=0.522 (e) P=0.246 |
|POLY 6 | P=0.111 P=0.561 (e) (e) P=0.545 (e) P=0.229 |
|LOGISTIC REGRESSION| P=0.084 P=0.602 (e) (e) P=0.508 (e) P=0.241 |
|COCH-ARM / FISHERS | P=0.091 P=0.514 (e) (e) P=0.505 (e) P=0.252 |
|ORDER RESTRICTED | P=0.050 (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 2
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Adrenal Medulla |
| Pheochromocytoma Benign |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 8/52 (15%) 3/55 (5%) 4/53 (8%) 2/53 (4%) 2/53 (4%) 4/52 (8%) 0/53 (0%) |
|POLY-3 RATE (b) | 8/33.26 3/38.95 4/40.27 2/37.58 2/36.68 4/42.10 0/31.91 |
|POLY-3 PERCENT (g) | 24.1% 7.7% 9.9% 5.3% 5.5% 9.5% 0.0% |
|TERMINAL (d) | 3/15 (20%) 2/25 (8%) 2/26 (8%) 1/22 (5%) 1/16 (6%) 2/23 (9%) 0/7 (0%) |
|FIRST INCIDENCE | 531 607 586 660 709 618 --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.047N* P=0.028N* P=0.050N P=0.020N* P=0.031N* P=0.047N* P=0.018N* |
|POLY 3 | P=0.027N* P=0.052N P=0.093N P=0.025N* P=0.027N* P=0.081N P=0.003N** |
|POLY 1.5 | P=0.023N* P=0.064N P=0.115N P=0.028N* P=0.032N* P=0.107N P=0.003N** |
|POLY 6 | P=0.043N* P=0.039N* P=0.072N P=0.022N* P=0.024N* P=0.059N P=0.005N** |
|LOGISTIC REGRESSION| P=0.019N* P=0.052N P=0.097N P=0.025N* P=0.026N* P=0.087N P=0.004N** |
|COCH-ARM / FISHERS | P=0.019N* P=0.084N P=0.170N P=0.043N* P=0.043N* P=0.179N P=0.003N** |
|ORDER RESTRICTED | P<0.001N** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Adrenal Medulla |
| Pheochromocytoma: Benign, Complex, Malignant, NOS |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 8/52 (15%) 3/55 (5%) 5/53 (9%) 3/53 (6%) 3/53 (6%) 5/52 (10%) 0/53 (0%) |
|POLY-3 RATE (b) | 8/33.26 3/38.95 5/40.34 3/38.25 3/36.68 5/42.10 0/31.91 |
|POLY-3 PERCENT (g) | 24.1% 7.7% 12.4% 7.8% 8.2% 11.9% 0.0% |
|TERMINAL (d) | 3/15 (20%) 2/25 (8%) 2/26 (8%) 1/22 (5%) 2/16 (13%) 3/23 (13%) 0/7 (0%) |
|FIRST INCIDENCE | 531 607 586 500 709 618 --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.068N P=0.028N* P=0.086N P=0.048N* P=0.067N P=0.081N P=0.018N* |
|POLY 3 | P=0.037N* P=0.052N P=0.158N P=0.055N P=0.064N P=0.140N P=0.003N** |
|POLY 1.5 | P=0.029N* P=0.064N P=0.191N P=0.064N P=0.073N P=0.179N P=0.003N** |
|POLY 6 | P=0.062N P=0.039N* P=0.126N P=0.050N P=0.060N P=0.107N P=0.005N** |
|LOGISTIC REGRESSION| P=0.024N* P=0.052N P=0.158N P=0.064N P=0.056N P=0.140N P=0.004N** |
|COCH-ARM / FISHERS | P=0.024N* P=0.084N P=0.265N P=0.095N P=0.095N P=0.277N P=0.003N** |
|ORDER RESTRICTED | P=0.002N** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 3
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Brain |
| Astrocytoma Malignant |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 2/53 (4%) 0/55 (0%) 0/53 (0%) 0/53 (0%) 1/53 (2%) 0/53 (0%) 0/53 (0%) |
|POLY-3 RATE (b) | 2/31.82 0/38.53 0/39.60 0/37.32 1/37.19 0/42.13 0/31.91 |
|POLY-3 PERCENT (g) | 6.3% 0.0% 0.0% 0.0% 2.7% 0.0% 0.0% |
|TERMINAL (d) | 1/15 (7%) 0/25 (0%) 0/26 (0%) 0/22 (0%) 0/16 (0%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | 600 --- --- --- 541 --- --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.259N P=0.165N P=0.156N P=0.183N P=0.448N P=0.158N P=0.301N |
|POLY 3 | P=0.250N P=0.196N P=0.191N P=0.202N P=0.445N P=0.181N P=0.235N |
|POLY 1.5 | P=0.250N P=0.209N P=0.206N P=0.211N P=0.464N P=0.198N P=0.231N |
|POLY 6 | P=0.274N P=0.179N P=0.176N P=0.196N P=0.429N P=0.165N P=0.254N |
|LOGISTIC REGRESSION| P=0.245N P=0.197N P=0.194N P=0.202N P=0.480N P=0.185N P=0.240N |
|COCH-ARM / FISHERS | P=0.245N P=0.238N P=0.248N P=0.248N P=0.500N P=0.248N P=0.248N |
|ORDER RESTRICTED | P=0.020N* (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Brain |
| Oligodendroglioma, Glioma, or Astrocytoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 3/53 (6%) 0/55 (0%) 0/53 (0%) 0/53 (0%) 1/53 (2%) 0/53 (0%) 0/53 (0%) |
|POLY-3 RATE (b) | 3/32.80 0/38.53 0/39.60 0/37.32 1/37.19 0/42.13 0/31.91 |
|POLY-3 PERCENT (g) | 9.2% 0.0% 0.0% 0.0% 2.7% 0.0% 0.0% |
|TERMINAL (d) | 1/15 (7%) 0/25 (0%) 0/26 (0%) 0/22 (0%) 0/16 (0%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | 201 --- --- --- 541 --- --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.150N P=0.082N P=0.079N P=0.093N P=0.270N P=0.080N P=0.156N |
|POLY 3 | P=0.149N P=0.091N P=0.088N P=0.096N P=0.260N P=0.080N P=0.121N |
|POLY 1.5 | P=0.146N P=0.100N P=0.098N P=0.101N P=0.276N P=0.092N P=0.117N |
|POLY 6 | P=0.166N P=0.079N P=0.077N P=0.091N P=0.245N P=0.069N P=0.138N |
|LOGISTIC REGRESSION| P=0.153N P=0.128N P=0.156N P=0.155N P=0.338N P=0.177N P=0.128N |
|COCH-ARM / FISHERS | P=0.144N P=0.115N P=0.121N P=0.121N P=0.309N P=0.121N P=0.121N |
|ORDER RESTRICTED | P=0.003N** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 4
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Heart |
| Schwannoma Malignant |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 0/52 (0%) 1/54 (2%) 2/53 (4%) 0/53 (0%) 2/53 (4%) 0/51 (0%) 0/51 (0%) |
|POLY-3 RATE (b) | 0/31.37 1/37.81 2/40.29 0/37.32 2/36.86 0/41.13 0/30.95 |
|POLY-3 PERCENT (g) | 0.0% 2.6% 5.0% 0.0% 5.4% 0.0% 0.0% |
|TERMINAL (d) | 0/15 (0%) 0/24 (0%) 0/26 (0%) 0/22 (0%) 0/16 (0%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | --- 652 602 --- 680 --- --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.299N P=0.578 P=0.312 (e) P=0.303 (e) (e) |
|POLY 3 | P=0.218N P=0.537 P=0.296 (e) P=0.274 (e) (e) |
|POLY 1.5 | P=0.234N P=0.523 P=0.275 (e) P=0.261 (e) (e) |
|POLY 6 | P=0.220N P=0.558 P=0.325 (e) P=0.287 (e) (e) |
|LOGISTIC REGRESSION| P=0.264N P=0.526 P=0.253 (e) P=0.282 (e) (e) |
|COCH-ARM / FISHERS | P=0.265N P=0.509 P=0.252 (e) P=0.252 (e) (e) |
|ORDER RESTRICTED | P=0.443N (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Intestine Small: Jejunum |
| Leiomyosarcoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 0/53 (0%) 0/55 (0%) 2/53 (4%) 0/53 (0%) 0/53 (0%) 0/53 (0%) 0/53 (0%) |
|POLY-3 RATE (b) | 0/31.38 0/38.53 2/39.60 0/37.32 0/36.61 0/42.13 0/31.91 |
|POLY-3 PERCENT (g) | 0.0% 0.0% 5.1% 0.0% 0.0% 0.0% 0.0% |
|TERMINAL (d) | 0/15 (0%) 0/25 (0%) 2/26 (8%) 0/22 (0%) 0/16 (0%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | --- --- 727 (T) --- --- --- --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.448N (e) P=0.365 (e) (e) (e) (e) |
|POLY 3 | P=0.265N (e) P=0.292 (e) (e) (e) (e) |
|POLY 1.5 | P=0.294N (e) P=0.272 (e) (e) (e) (e) |
|POLY 6 | P=0.260N (e) P=0.317 (e) (e) (e) (e) |
|LOGISTIC REGRESSION| (e) (e) P=0.365 (e) (e) (e) (e) |
|COCH-ARM / FISHERS | P=0.344N (e) P=0.248 (e) (e) (e) (e) |
|ORDER RESTRICTED | P=0.412N (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 5
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Intestine Small: Site Unspecified |
| Leiomyosarcoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 0/53 (0%) 0/55 (0%) 2/53 (4%) 0/53 (0%) 0/53 (0%) 0/53 (0%) 0/53 (0%) |
|POLY-3 RATE (b) | 0/31.38 0/38.53 2/39.60 0/37.32 0/36.61 0/42.13 0/31.91 |
|POLY-3 PERCENT (g) | 0.0% 0.0% 5.1% 0.0% 0.0% 0.0% 0.0% |
|TERMINAL (d) | 0/15 (0%) 0/25 (0%) 2/26 (8%) 0/22 (0%) 0/16 (0%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | --- --- 727 (T) --- --- --- --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.448N (e) P=0.365 (e) (e) (e) (e) |
|POLY 3 | P=0.265N (e) P=0.292 (e) (e) (e) (e) |
|POLY 1.5 | P=0.294N (e) P=0.272 (e) (e) (e) (e) |
|POLY 6 | P=0.260N (e) P=0.317 (e) (e) (e) (e) |
|LOGISTIC REGRESSION| (e) (e) P=0.365 (e) (e) (e) (e) |
|COCH-ARM / FISHERS | P=0.344N (e) P=0.248 (e) (e) (e) (e) |
|ORDER RESTRICTED | P=0.412N (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Islets, Pancreatic |
| Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 0/52 (0%) 2/54 (4%) 0/53 (0%) 1/53 (2%) 0/53 (0%) 0/52 (0%) 1/51 (2%) |
|POLY-3 RATE (b) | 0/31.36 2/38.32 0/39.60 1/37.32 0/36.61 0/41.53 1/30.67 |
|POLY-3 PERCENT (g) | 0.0% 5.2% 0.0% 2.7% 0.0% 0.0% 3.3% |
|TERMINAL (d) | 0/15 (0%) 1/25 (4%) 0/26 (0%) 1/22 (5%) 0/16 (0%) 0/23 (0%) 1/7 (14%) |
|FIRST INCIDENCE | --- 652 --- 727 (T) --- --- 727 (T) |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.479 P=0.343 (e) P=0.576 (e) (e) P=0.348 |
|POLY 3 | P=0.571N P=0.283 (e) P=0.535 (e) (e) P=0.496 |
|POLY 1.5 | P=0.606N P=0.265 (e) P=0.526 (e) (e) P=0.499 |
|POLY 6 | P=0.540N P=0.312 (e) P=0.543 (e) (e) P=0.481 |
|LOGISTIC REGRESSION| P=0.575 P=0.292 (e) P=0.576 (e) (e) P=0.348 |
|COCH-ARM / FISHERS | P=0.622 P=0.257 (e) P=0.505 (e) (e) P=0.495 |
|ORDER RESTRICTED | P=0.315 (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 6
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Islets, Pancreatic |
| Carcinoma or Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 0/52 (0%) 2/54 (4%) 1/53 (2%) 1/53 (2%) 0/53 (0%) 0/52 (0%) 1/51 (2%) |
|POLY-3 RATE (b) | 0/31.36 2/38.32 1/40.08 1/37.32 0/36.61 0/41.53 1/30.67 |
|POLY-3 PERCENT (g) | 0.0% 5.2% 2.5% 2.7% 0.0% 0.0% 3.3% |
|TERMINAL (d) | 0/15 (0%) 1/25 (4%) 0/26 (0%) 1/22 (5%) 0/16 (0%) 0/23 (0%) 1/7 (14%) |
|FIRST INCIDENCE | --- 652 586 727 (T) --- --- 727 (T) |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.621 P=0.343 P=0.551 P=0.576 (e) (e) P=0.348 |
|POLY 3 | P=0.441N P=0.283 P=0.548 P=0.535 (e) (e) P=0.496 |
|POLY 1.5 | P=0.476N P=0.265 P=0.532 P=0.526 (e) (e) P=0.499 |
|POLY 6 | P=0.412N P=0.312 P=0.568 P=0.543 (e) (e) P=0.481 |
|LOGISTIC REGRESSION| P=0.549N P=0.292 P=0.494 P=0.576 (e) (e) P=0.348 |
|COCH-ARM / FISHERS | P=0.523N P=0.257 P=0.505 P=0.505 (e) (e) P=0.495 |
|ORDER RESTRICTED | P=0.369 (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Kidney: Renal Tubule |
| Nephroblastoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 1/53 (2%) 2/55 (4%) 1/53 (2%) 1/53 (2%) 0/53 (0%) 0/52 (0%) 2/53 (4%) |
|POLY-3 RATE (b) | 1/32.37 2/40.46 1/40.57 1/38.09 0/36.61 0/41.53 2/33.85 |
|POLY-3 PERCENT (g) | 3.1% 4.9% 2.5% 2.6% 0.0% 0.0% 5.9% |
|TERMINAL (d) | 0/15 (0%) 0/25 (0%) 0/26 (0%) 0/22 (0%) 0/16 (0%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | 176 223 236 448 --- --- 188 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.523 P=0.525 P=0.749N P=0.741N P=0.504N P=0.496N P=0.509 |
|POLY 3 | P=0.533 P=0.577 P=0.708N P=0.724N P=0.475N P=0.451N P=0.516 |
|POLY 1.5 | P=0.527 P=0.551 P=0.727N P=0.735N P=0.485N P=0.469N P=0.517 |
|POLY 6 | P=0.552 P=0.611 P=0.685N P=0.713N P=0.467N P=0.431N P=0.493 |
|LOGISTIC REGRESSION| P=0.500 P=0.422 P=0.497 P=0.581 P=0.494N P=0.849N P=0.435 |
|COCH-ARM / FISHERS | P=0.514 P=0.514 P=0.752N P=0.752N P=0.500N P=0.505N P=0.500 |
|ORDER RESTRICTED | P=0.353 (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 7
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Liver |
| Cholangiocarcinoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 0/53 (0%) 0/55 (0%) 1/53 (2%) 0/53 (0%) 5/53 (9%) 6/51 (12%) 22/53 (42%) |
|POLY-3 RATE (b) | 0/31.38 0/38.53 1/39.60 0/37.32 5/36.89 6/42.75 22/36.46 |
|POLY-3 PERCENT (g) | 0.0% 0.0% 2.5% 0.0% 13.6% 14.0% 60.3% |
|TERMINAL (d) | 0/15 (0%) 0/25 (0%) 1/26 (4%) 0/22 (0%) 3/16 (19%) 1/23 (4%) 6/7 (86%) |
|FIRST INCIDENCE | --- --- 727 (T) --- 659 618 562 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P<0.001 ** (e) P=0.610 (e) P=0.047 * P=0.068 P<0.001 ** |
|POLY 3 | P<0.001 ** (e) P=0.546 (e) P=0.045 * P=0.040 * P<0.001 ** |
|POLY 1.5 | P<0.001 ** (e) P=0.530 (e) P=0.039 * P=0.028 * P<0.001 ** |
|POLY 6 | P<0.001 ** (e) P=0.565 (e) P=0.050 P=0.060 P<0.001 ** |
|LOGISTIC REGRESSION| P<0.001 ** (e) P=0.610 (e) P=0.052 P=0.026 * P<0.001 ** |
|COCH-ARM / FISHERS | P<0.001 ** (e) P=0.500 (e) P=0.028 * P=0.012 * P<0.001 ** |
|ORDER RESTRICTED | P<0.001 ** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Liver |
| Hepatocellular Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 1/53 (2%) 2/55 (4%) 1/53 (2%) 0/53 (0%) 2/53 (4%) 4/51 (8%) 7/53 (13%) |
|POLY-3 RATE (b) | 1/31.38 2/38.81 1/40.03 0/37.32 2/36.68 4/41.43 7/33.51 |
|POLY-3 PERCENT (g) | 3.2% 5.2% 2.5% 0.0% 5.5% 9.7% 20.9% |
|TERMINAL (d) | 1/15 (7%) 1/25 (4%) 0/26 (0%) 0/22 (0%) 1/16 (6%) 4/23 (17%) 2/7 (29%) |
|FIRST INCIDENCE | 727 (T) 652 602 --- 709 727 (T) 562 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P<0.001 ** P=0.661 P=0.664N P=0.424N P=0.547 P=0.323 P=0.009 ** |
|POLY 3 | P<0.001 ** P=0.574 P=0.704N P=0.465N P=0.554 P=0.274 P=0.033 * |
|POLY 1.5 | P<0.001 ** P=0.548 P=0.725N P=0.475N P=0.535 P=0.235 P=0.034 * |
|POLY 6 | P<0.001 ** P=0.610 P=0.677N P=0.457N P=0.573 P=0.319 P=0.027 * |
|LOGISTIC REGRESSION| P<0.001 ** P=0.616 P=0.723N (e) P=0.579 P=0.323 P=0.027 * |
|COCH-ARM / FISHERS | P<0.001 ** P=0.514 P=0.752N P=0.500N P=0.500 P=0.170 P=0.030 * |
|ORDER RESTRICTED | P=0.003 ** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 8
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Liver |
| Hepatocellular Carcinoma or Hepatocellular Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 1/53 (2%) 2/55 (4%) 1/53 (2%) 1/53 (2%) 2/53 (4%) 4/51 (8%) 7/53 (13%) |
|POLY-3 RATE (b) | 1/31.38 2/38.81 1/40.03 1/37.32 2/36.68 4/41.43 7/33.51 |
|POLY-3 PERCENT (g) | 3.2% 5.2% 2.5% 2.7% 5.5% 9.7% 20.9% |
|TERMINAL (d) | 1/15 (7%) 1/25 (4%) 0/26 (0%) 1/22 (5%) 1/16 (6%) 4/23 (17%) 2/7 (29%) |
|FIRST INCIDENCE | 727 (T) 652 602 727 (T) 709 727 (T) 562 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P<0.001 ** P=0.661 P=0.664N P=0.675N P=0.547 P=0.323 P=0.009 ** |
|POLY 3 | P<0.001 ** P=0.574 P=0.704N P=0.722N P=0.554 P=0.274 P=0.033 * |
|POLY 1.5 | P<0.001 ** P=0.548 P=0.725N P=0.732N P=0.535 P=0.235 P=0.034 * |
|POLY 6 | P<0.001 ** P=0.610 P=0.677N P=0.711N P=0.573 P=0.319 P=0.027 * |
|LOGISTIC REGRESSION| P<0.001 ** P=0.616 P=0.723N P=0.675N P=0.579 P=0.323 P=0.027 * |
|COCH-ARM / FISHERS | P<0.001 ** P=0.514 P=0.752N P=0.752N P=0.500 P=0.170 P=0.030 * |
|ORDER RESTRICTED | P=0.005 ** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Liver |
| Hepatocellular Carcinoma, Hepatocellular Adenoma, |
| or Hepatoblastoma |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 1/53 (2%) 2/55 (4%) 1/53 (2%) 1/53 (2%) 2/53 (4%) 4/51 (8%) 7/53 (13%) |
|POLY-3 RATE (b) | 1/31.38 2/38.81 1/40.03 1/37.32 2/36.68 4/41.43 7/33.51 |
|POLY-3 PERCENT (g) | 3.2% 5.2% 2.5% 2.7% 5.5% 9.7% 20.9% |
|TERMINAL (d) | 1/15 (7%) 1/25 (4%) 0/26 (0%) 1/22 (5%) 1/16 (6%) 4/23 (17%) 2/7 (29%) |
|FIRST INCIDENCE | 727 (T) 652 602 727 (T) 709 727 (T) 562 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P<0.001 ** P=0.661 P=0.664N P=0.675N P=0.547 P=0.323 P=0.009 ** |
|POLY 3 | P<0.001 ** P=0.574 P=0.704N P=0.722N P=0.554 P=0.274 P=0.033 * |
|POLY 1.5 | P<0.001 ** P=0.548 P=0.725N P=0.732N P=0.535 P=0.235 P=0.034 * |
|POLY 6 | P<0.001 ** P=0.610 P=0.677N P=0.711N P=0.573 P=0.319 P=0.027 * |
|LOGISTIC REGRESSION| P<0.001 ** P=0.616 P=0.723N P=0.675N P=0.579 P=0.323 P=0.027 * |
|COCH-ARM / FISHERS | P<0.001 ** P=0.514 P=0.752N P=0.752N P=0.500 P=0.170 P=0.030 * |
|ORDER RESTRICTED | P=0.005 ** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 9
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Liver |
| Hepatocholangioma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 0/53 (0%) 0/55 (0%) 0/53 (0%) 0/53 (0%) 0/53 (0%) 0/51 (0%) 3/53 (6%) |
|POLY-3 RATE (b) | 0/31.38 0/38.53 0/39.60 0/37.32 0/36.61 0/41.43 3/32.40 |
|POLY-3 PERCENT (g) | 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 9.3% |
|TERMINAL (d) | 0/15 (0%) 0/25 (0%) 0/26 (0%) 0/22 (0%) 0/16 (0%) 0/23 (0%) 1/7 (14%) |
|FIRST INCIDENCE | --- --- --- --- --- --- 660 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P<0.001 ** (e) (e) (e) (e) (e) P=0.068 |
|POLY 3 | P<0.001 ** (e) (e) (e) (e) (e) P=0.122 |
|POLY 1.5 | P<0.001 ** (e) (e) (e) (e) (e) P=0.124 |
|POLY 6 | P<0.001 ** (e) (e) (e) (e) (e) P=0.109 |
|LOGISTIC REGRESSION| P<0.001 ** (e) (e) (e) (e) (e) P=0.100 |
|COCH-ARM / FISHERS | P<0.001 ** (e) (e) (e) (e) (e) P=0.121 |
|ORDER RESTRICTED | P<0.001 ** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Lung |
| Cystic Keratinizing Epithelioma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 0/53 (0%) 0/55 (0%) 0/53 (0%) 0/53 (0%) 1/53 (2%) 11/51 (22%) 35/51 (69%) |
|POLY-3 RATE (b) | 0/31.38 0/38.53 0/39.60 0/37.32 1/36.61 11/42.26 35/41.94 |
|POLY-3 PERCENT (g) | 0.0% 0.0% 0.0% 0.0% 2.7% 26.0% 83.5% |
|TERMINAL (d) | 0/15 (0%) 0/25 (0%) 0/26 (0%) 0/22 (0%) 1/16 (6%) 5/23 (22%) 6/7 (86%) |
|FIRST INCIDENCE | --- --- --- --- 727 (T) 588 484 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P<0.001 ** (e) (e) (e) P=0.513 P=0.009 ** P<0.001 ** |
|POLY 3 | P<0.001 ** (e) (e) (e) P=0.531 P=0.002 ** P<0.001 ** |
|POLY 1.5 | P<0.001 ** (e) (e) (e) P=0.520 P<0.001 ** P<0.001 ** |
|POLY 6 | P<0.001 ** (e) (e) (e) P=0.540 P=0.005 ** P<0.001 ** |
|LOGISTIC REGRESSION| P<0.001 ** (e) (e) (e) P=0.513 P=0.004 ** P<0.001 ** |
|COCH-ARM / FISHERS | P<0.001 ** (e) (e) (e) P=0.500 P<0.001 ** P<0.001 ** |
|ORDER RESTRICTED | P<0.001 ** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 10
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Lung |
| Squamous Cell Carcinoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 0/53 (0%) 0/55 (0%) 0/53 (0%) 0/53 (0%) 0/53 (0%) 1/51 (2%) 2/51 (4%) |
|POLY-3 RATE (b) | 0/31.38 0/38.53 0/39.60 0/37.32 0/36.61 1/41.13 2/31.91 |
|POLY-3 PERCENT (g) | 0.0% 0.0% 0.0% 0.0% 0.0% 2.4% 6.3% |
|TERMINAL (d) | 0/15 (0%) 0/25 (0%) 0/26 (0%) 0/22 (0%) 0/16 (0%) 1/23 (4%) 0/7 (0%) |
|FIRST INCIDENCE | --- --- --- --- --- 727 (T) 555 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.003 ** (e) (e) (e) (e) P=0.585 P=0.265 |
|POLY 3 | P=0.005 ** (e) (e) (e) (e) P=0.553 P=0.239 |
|POLY 1.5 | P=0.005 ** (e) (e) (e) (e) P=0.532 P=0.238 |
|POLY 6 | P=0.005 ** (e) (e) (e) (e) P=0.575 P=0.229 |
|LOGISTIC REGRESSION| P=0.006 ** (e) (e) (e) (e) P=0.585 P=0.230 |
|COCH-ARM / FISHERS | P=0.006 ** (e) (e) (e) (e) P=0.490 P=0.238 |
|ORDER RESTRICTED | P=0.021 * (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Mammary Gland |
| Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 2/53 (4%) 0/55 (0%) 2/53 (4%) 0/53 (0%) 1/53 (2%) 0/53 (0%) 0/53 (0%) |
|POLY-3 RATE (b) | 2/31.38 0/38.53 2/40.21 0/37.32 1/36.61 0/42.13 0/31.91 |
|POLY-3 PERCENT (g) | 6.4% 0.0% 5.0% 0.0% 2.7% 0.0% 0.0% |
|TERMINAL (d) | 2/15 (13%) 0/25 (0%) 1/26 (4%) 0/22 (0%) 1/16 (6%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | 727 (T) --- 533 --- 727 (T) --- --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.188N P=0.134N P=0.523N P=0.157N P=0.477N P=0.149N P=0.416N |
|POLY 3 | P=0.125N P=0.193N P=0.602N P=0.200N P=0.446N P=0.178N P=0.232N |
|POLY 1.5 | P=0.128N P=0.208N P=0.636N P=0.210N P=0.465N P=0.197N P=0.229N |
|POLY 6 | P=0.134N P=0.174N P=0.560N P=0.190N P=0.429N P=0.160N P=0.248N |
|LOGISTIC REGRESSION| P=0.137N (e) P=0.608N (e) P=0.477N (e) (e) |
|COCH-ARM / FISHERS | P=0.137N P=0.238N P=0.691N P=0.248N P=0.500N P=0.248N P=0.248N |
|ORDER RESTRICTED | P=0.070N (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 11
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Mammary Gland |
| Carcinoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 6/53 (11%) 7/55 (13%) 9/53 (17%) 5/53 (9%) 0/53 (0%) 1/53 (2%) 1/53 (2%) |
|POLY-3 RATE (b) | 6/32.44 7/39.35 9/40.77 5/38.47 0/36.61 1/42.13 1/32.91 |
|POLY-3 PERCENT (g) | 18.5% 17.8% 22.1% 13.0% 0.0% 2.4% 3.0% |
|TERMINAL (d) | 3/15 (20%) 3/25 (12%) 6/26 (23%) 3/22 (14%) 0/16 (0%) 1/23 (4%) 0/7 (0%) |
|FIRST INCIDENCE | 400 580 533 496 --- 727 (T) 72 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.005N** P=0.397N P=0.557N P=0.299N P=0.012N* P=0.015N* P=0.160N |
|POLY 3 | P<0.001N** P=0.591N P=0.466 P=0.379N P=0.009N** P=0.024N* P=0.049N* |
|POLY 1.5 | P<0.001N** P=0.598 P=0.399 P=0.413N P=0.011N* P=0.032N* P=0.048N* |
|POLY 6 | P<0.001N** P=0.514N P=0.551 P=0.347N P=0.007N** P=0.017N* P=0.059N |
|LOGISTIC REGRESSION| P<0.001N** P=0.569N P=0.474 P=0.397N P=0.011N* P=0.024N* P=0.058N |
|COCH-ARM / FISHERS | P<0.001N** P=0.529 P=0.289 P=0.500N P=0.013N* P=0.056N P=0.056N |
|ORDER RESTRICTED | P=0.020N* (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Mammary Gland |
| Carcinoma or Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 7/53 (13%) 7/55 (13%) 10/53 (19%) 5/53 (9%) 1/53 (2%) 1/53 (2%) 1/53 (2%) |
|POLY-3 RATE (b) | 7/32.44 7/39.35 10/40.77 5/38.47 1/36.61 1/42.13 1/32.91 |
|POLY-3 PERCENT (g) | 21.6% 17.8% 24.5% 13.0% 2.7% 2.4% 3.0% |
|TERMINAL (d) | 4/15 (27%) 3/25 (12%) 7/26 (27%) 3/22 (14%) 1/16 (6%) 1/23 (4%) 0/7 (0%) |
|FIRST INCIDENCE | 400 580 533 496 727 (T) 727 (T) 72 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.004N** P=0.270N P=0.496N P=0.191N P=0.022N* P=0.006N** P=0.117N |
|POLY 3 | P<0.001N** P=0.459N P=0.493 P=0.259N P=0.017N* P=0.010N* P=0.024N* |
|POLY 1.5 | P<0.001N** P=0.514N P=0.419 P=0.292N P=0.021N* P=0.015N* P=0.024N* |
|POLY 6 | P<0.001N** P=0.376N P=0.586 P=0.228N P=0.014N* P=0.007N** P=0.030N* |
|LOGISTIC REGRESSION| P<0.001N** P=0.426N P=0.522 P=0.271N P=0.016N* P=0.009N** P=0.032N* |
|COCH-ARM / FISHERS | P<0.001N** P=0.583N P=0.299 P=0.380N P=0.030N* P=0.030N* P=0.030N* |
|ORDER RESTRICTED | P=0.017N* (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 12
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Mammary Gland |
| Fibroadenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 39/53 (74%) 31/55 (56%) 35/53 (66%) 38/53 (72%) 39/53 (74%) 29/53 (55%) 11/53 (21%) |
|POLY-3 RATE (b) | 39/45.19 31/45.30 35/47.68 38/47.78 39/48.22 29/46.84 11/35.90 |
|POLY-3 PERCENT (g) | 86.3% 68.4% 73.4% 79.5% 80.9% 61.9% 30.6% |
|TERMINAL (d) | 11/15 (73%) 18/25 (72%) 18/26 (69%) 16/22 (73%) 10/16 (63%) 14/23 (61%) 3/7 (43%) |
|FIRST INCIDENCE | 309 356 188 385 247 440 258 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.003N** P=0.003N** P=0.010N* P=0.095N P=0.250N P<0.001N** P<0.001N** |
|POLY 3 | P<0.001N** P=0.029N* P=0.085N P=0.263N P=0.327N P=0.004N** P<0.001N** |
|POLY 1.5 | P<0.001N** P=0.027N* P=0.095N P=0.274N P=0.387N P=0.005N** P<0.001N** |
|POLY 6 | P<0.001N** P=0.033N* P=0.101N P=0.318N P=0.304N P=0.006N** P<0.001N** |
|LOGISTIC REGRESSION| P<0.001N** P=0.015N* P=0.127N P=0.283N P=0.445N P=0.004N** P<0.001N** |
|COCH-ARM / FISHERS | P<0.001N** P=0.047N* P=0.263N P=0.500N P=0.587N P=0.034N* P<0.001N** |
|ORDER RESTRICTED | P<0.001N** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Mammary Gland |
| Fibroma, Fibroadenoma or Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 40/53 (75%) 31/55 (56%) 36/53 (68%) 38/53 (72%) 39/53 (74%) 29/53 (55%) 11/53 (21%) |
|POLY-3 RATE (b) | 40/45.19 31/45.30 36/48.29 38/47.78 39/48.22 29/46.84 11/35.90 |
|POLY-3 PERCENT (g) | 88.5% 68.4% 74.6% 79.5% 80.9% 61.9% 30.6% |
|TERMINAL (d) | 12/15 (80%) 18/25 (72%) 18/26 (69%) 16/22 (73%) 10/16 (63%) 14/23 (61%) 3/7 (43%) |
|FIRST INCIDENCE | 309 356 188 385 247 440 258 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.002N** P=0.002N** P=0.009N** P=0.070N P=0.210N P<0.001N** P<0.001N** |
|POLY 3 | P<0.001N** P=0.013N* P=0.058N P=0.165N P=0.219N P=0.002N** P<0.001N** |
|POLY 1.5 | P<0.001N** P=0.013N* P=0.074N P=0.182N P=0.279N P=0.002N** P<0.001N** |
|POLY 6 | P<0.001N** P=0.014N* P=0.062N P=0.203N P=0.195N P=0.002N** P<0.001N** |
|LOGISTIC REGRESSION| P<0.001N** P=0.008N** P=0.118N P=0.194N P=0.344N P=0.002N** P<0.001N** |
|COCH-ARM / FISHERS | P<0.001N** P=0.029N* P=0.259N P=0.413N P=0.500N P=0.020N* P<0.001N** |
|ORDER RESTRICTED | P<0.001N** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 13
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Mammary Gland |
| Fibroma, Fibroadenoma, Carcinoma, or Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 42/53 (79%) 36/55 (65%) 38/53 (72%) 39/53 (74%) 39/53 (74%) 29/53 (55%) 12/53 (23%) |
|POLY-3 RATE (b) | 42/46.17 36/46.12 38/48.57 39/48.24 39/48.22 29/46.84 12/36.90 |
|POLY-3 PERCENT (g) | 91.0% 78.1% 78.2% 80.8% 80.9% 61.9% 32.5% |
|TERMINAL (d) | 12/15 (80%) 19/25 (76%) 19/26 (73%) 16/22 (73%) 10/16 (63%) 14/23 (61%) 3/7 (43%) |
|FIRST INCIDENCE | 309 356 188 385 247 440 72 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P<0.001N** P=0.005N** P=0.007N** P=0.054N P=0.143N P<0.001N** P<0.001N** |
|POLY 3 | P<0.001N** P=0.064N P=0.064N P=0.114N P=0.121N P<0.001N** P<0.001N** |
|POLY 1.5 | P<0.001N** P=0.056N P=0.073N P=0.122N P=0.149N P<0.001N** P<0.001N** |
|POLY 6 | P<0.001N** P=0.072N P=0.075N P=0.149N P=0.118N P<0.001N** P<0.001N** |
|LOGISTIC REGRESSION| P<0.001N** P=0.023N* P=0.104N P=0.134N P=0.191N P<0.001N** P<0.001N** |
|COCH-ARM / FISHERS | P<0.001N** P=0.083N P=0.249N P=0.324N P=0.324N P=0.006N** P<0.001N** |
|ORDER RESTRICTED | P<0.001N** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Oral Cavity (Oral Mucosa, Tongue, Pharynx, Tooth, Gingiva) |
| Squamous Cell Carcinoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 0/53 (0%) 1/55 (2%) 1/53 (2%) 1/53 (2%) 2/53 (4%) 2/53 (4%) 7/53 (13%) |
|POLY-3 RATE (b) | 0/31.38 1/38.71 1/39.88 1/37.32 2/36.99 2/42.83 7/34.71 |
|POLY-3 PERCENT (g) | 0.0% 2.6% 2.5% 2.7% 5.4% 4.7% 20.2% |
|TERMINAL (d) | 0/15 (0%) 0/25 (0%) 0/26 (0%) 1/22 (5%) 1/16 (6%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | --- 681 651 727 (T) 618 498 523 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P<0.001 ** P=0.602 P=0.595 P=0.576 P=0.280 P=0.328 P=0.011 * |
|POLY 3 | P<0.001 ** P=0.542 P=0.547 P=0.534 P=0.275 P=0.312 P=0.010 * |
|POLY 1.5 | P<0.001 ** P=0.527 P=0.531 P=0.525 P=0.261 P=0.285 P=0.009 ** |
|POLY 6 | P<0.001 ** P=0.562 P=0.567 P=0.543 P=0.289 P=0.342 P=0.009 ** |
|LOGISTIC REGRESSION| P<0.001 ** P=0.547 P=0.529 P=0.576 P=0.271 P=0.225 P=0.010 * |
|COCH-ARM / FISHERS | P<0.001 ** P=0.509 P=0.500 P=0.500 P=0.248 P=0.248 P=0.006 ** |
|ORDER RESTRICTED | P<0.001 ** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 14
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Oral Cavity (Oral Mucosa, Tongue, Pharynx, Tooth, Gingiva) |
| Squamous Cell Carcinoma, Papilloma Squamous, or Papilloma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 0/53 (0%) 1/55 (2%) 1/53 (2%) 1/53 (2%) 2/53 (4%) 2/53 (4%) 7/53 (13%) |
|POLY-3 RATE (b) | 0/31.38 1/38.71 1/39.88 1/37.32 2/36.99 2/42.83 7/34.71 |
|POLY-3 PERCENT (g) | 0.0% 2.6% 2.5% 2.7% 5.4% 4.7% 20.2% |
|TERMINAL (d) | 0/15 (0%) 0/25 (0%) 0/26 (0%) 1/22 (5%) 1/16 (6%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | --- 681 651 727 (T) 618 498 523 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P<0.001 ** P=0.602 P=0.595 P=0.576 P=0.280 P=0.328 P=0.011 * |
|POLY 3 | P<0.001 ** P=0.542 P=0.547 P=0.534 P=0.275 P=0.312 P=0.010 * |
|POLY 1.5 | P<0.001 ** P=0.527 P=0.531 P=0.525 P=0.261 P=0.285 P=0.009 ** |
|POLY 6 | P<0.001 ** P=0.562 P=0.567 P=0.543 P=0.289 P=0.342 P=0.009 ** |
|LOGISTIC REGRESSION| P<0.001 ** P=0.547 P=0.529 P=0.576 P=0.271 P=0.225 P=0.010 * |
|COCH-ARM / FISHERS | P<0.001 ** P=0.509 P=0.500 P=0.500 P=0.248 P=0.248 P=0.006 ** |
|ORDER RESTRICTED | P<0.001 ** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Oral Mucosa |
| Squamous Cell Carcinoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 0/53 (0%) 1/55 (2%) 1/53 (2%) 1/53 (2%) 2/53 (4%) 2/53 (4%) 7/53 (13%) |
|POLY-3 RATE (b) | 0/31.38 1/38.71 1/39.88 1/37.32 2/36.99 2/42.83 7/34.71 |
|POLY-3 PERCENT (g) | 0.0% 2.6% 2.5% 2.7% 5.4% 4.7% 20.2% |
|TERMINAL (d) | 0/15 (0%) 0/25 (0%) 0/26 (0%) 1/22 (5%) 1/16 (6%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | --- 681 651 727 (T) 618 498 523 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P<0.001 ** P=0.602 P=0.595 P=0.576 P=0.280 P=0.328 P=0.011 * |
|POLY 3 | P<0.001 ** P=0.542 P=0.547 P=0.534 P=0.275 P=0.312 P=0.010 * |
|POLY 1.5 | P<0.001 ** P=0.527 P=0.531 P=0.525 P=0.261 P=0.285 P=0.009 ** |
|POLY 6 | P<0.001 ** P=0.562 P=0.567 P=0.543 P=0.289 P=0.342 P=0.009 ** |
|LOGISTIC REGRESSION| P<0.001 ** P=0.547 P=0.529 P=0.576 P=0.271 P=0.225 P=0.010 * |
|COCH-ARM / FISHERS | P<0.001 ** P=0.509 P=0.500 P=0.500 P=0.248 P=0.248 P=0.006 ** |
|ORDER RESTRICTED | P<0.001 ** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 15
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Pancreas |
| Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 1/51 (2%) 0/55 (0%) 0/53 (0%) 0/53 (0%) 2/53 (4%) 0/52 (0%) 0/51 (0%) |
|POLY-3 RATE (b) | 1/31.35 0/38.53 0/39.60 0/37.32 2/36.63 0/41.53 0/30.95 |
|POLY-3 PERCENT (g) | 3.2% 0.0% 0.0% 0.0% 5.5% 0.0% 0.0% |
|TERMINAL (d) | 1/15 (7%) 0/25 (0%) 0/26 (0%) 0/22 (0%) 1/16 (6%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | 727 (T) --- --- --- 722 --- --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.600N P=0.398N P=0.390N P=0.424N P=0.536 P=0.415N P=0.652N |
|POLY 3 | P=0.431N P=0.459N P=0.454N P=0.465N P=0.554 P=0.445N P=0.503N |
|POLY 1.5 | P=0.433N P=0.472N P=0.469N P=0.473N P=0.538 P=0.463N P=0.500N |
|POLY 6 | P=0.463N P=0.439N P=0.435N P=0.457N P=0.572 P=0.424N P=0.516N |
|LOGISTIC REGRESSION| P=0.564N (e) (e) (e) P=0.571 (e) (e) |
|COCH-ARM / FISHERS | P=0.440N P=0.481N P=0.490N P=0.490N P=0.515 P=0.495N P=0.500N |
|ORDER RESTRICTED | P=0.254N (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Pancreas |
| Carcinoma or Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 1/51 (2%) 0/55 (0%) 0/53 (0%) 1/53 (2%) 2/53 (4%) 0/52 (0%) 1/51 (2%) |
|POLY-3 RATE (b) | 1/31.35 0/38.53 0/39.60 1/37.32 2/36.63 0/41.53 1/31.19 |
|POLY-3 PERCENT (g) | 3.2% 0.0% 0.0% 2.7% 5.5% 0.0% 3.2% |
|TERMINAL (d) | 1/15 (7%) 0/25 (0%) 0/26 (0%) 1/22 (5%) 1/16 (6%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | 727 (T) --- --- 727 (T) 722 --- 663 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.298 P=0.398N P=0.390N P=0.675N P=0.536 P=0.415N P=0.665 |
|POLY 3 | P=0.455 P=0.459N P=0.454N P=0.722N P=0.554 P=0.445N P=0.761 |
|POLY 1.5 | P=0.470 P=0.472N P=0.469N P=0.731N P=0.538 P=0.463N P=0.760N |
|POLY 6 | P=0.443 P=0.439N P=0.435N P=0.712N P=0.572 P=0.424N P=0.750 |
|LOGISTIC REGRESSION| P=0.392 (e) (e) P=0.675N P=0.571 (e) P=0.727 |
|COCH-ARM / FISHERS | P=0.483 P=0.481N P=0.490N P=0.743N P=0.515 P=0.495N P=0.752N |
|ORDER RESTRICTED | P=0.512 (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 16
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Pituitary Gland: Pars Distalis or Unspecified Site |
| Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 15/51 (29%) 18/54 (33%) 20/53 (38%) 16/53 (30%) 22/53 (42%) 14/53 (26%) 6/53 (11%) |
|POLY-3 RATE (b) | 15/32.57 18/41.27 20/43.98 16/40.27 22/39.95 14/43.88 6/32.96 |
|POLY-3 PERCENT (g) | 46.1% 43.6% 45.5% 39.7% 55.1% 31.9% 18.2% |
|TERMINAL (d) | 9/15 (60%) 8/25 (32%) 10/26 (39%) 8/22 (36%) 10/16 (63%) 7/23 (30%) 1/7 (14%) |
|FIRST INCIDENCE | 603 434 328 487 531 588 607 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.118N P=0.271N P=0.362N P=0.280N P=0.261 P=0.082N P=0.214N |
|POLY 3 | P=0.003N** P=0.511N P=0.574N P=0.377N P=0.289 P=0.150N P=0.011N* |
|POLY 1.5 | P=0.002N** P=0.561 P=0.473 P=0.447N P=0.221 P=0.234N P=0.011N* |
|POLY 6 | P=0.009N** P=0.356N P=0.424N P=0.313N P=0.372 P=0.087N P=0.015N* |
|LOGISTIC REGRESSION| P=0.002N** P=0.566N P=0.483 P=0.397N P=0.298 P=0.100N P=0.028N* |
|COCH-ARM / FISHERS | P=0.002N** P=0.412 P=0.245 P=0.551 P=0.139 P=0.451N P=0.019N* |
|ORDER RESTRICTED | P=0.019N* (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Pituitary Gland: Pars Distalis or Unspecified Site |
| Carcinoma or Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 15/51 (29%) 18/54 (33%) 20/53 (38%) 17/53 (32%) 22/53 (42%) 15/53 (28%) 6/53 (11%) |
|POLY-3 RATE (b) | 15/32.57 18/41.27 20/43.98 17/40.27 22/39.95 15/43.88 6/32.96 |
|POLY-3 PERCENT (g) | 46.1% 43.6% 45.5% 42.2% 55.1% 34.2% 18.2% |
|TERMINAL (d) | 9/15 (60%) 8/25 (32%) 10/26 (39%) 9/22 (41%) 10/16 (63%) 8/23 (35%) 1/7 (14%) |
|FIRST INCIDENCE | 603 434 328 487 531 588 607 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.138N P=0.271N P=0.362N P=0.340N P=0.261 P=0.111N P=0.214N |
|POLY 3 | P=0.004N** P=0.511N P=0.574N P=0.463N P=0.289 P=0.205N P=0.011N* |
|POLY 1.5 | P=0.002N** P=0.561 P=0.473 P=0.532N P=0.221 P=0.304N P=0.011N* |
|POLY 6 | P=0.013N* P=0.356N P=0.424N P=0.398N P=0.372 P=0.125N P=0.015N* |
|LOGISTIC REGRESSION| P=0.002N** P=0.566N P=0.483 P=0.478N P=0.298 P=0.135N P=0.028N* |
|COCH-ARM / FISHERS | P=0.002N** P=0.412 P=0.245 P=0.468 P=0.139 P=0.536N P=0.019N* |
|ORDER RESTRICTED | P=0.017N* (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 17
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Pituitary Gland: Pars Intermedia |
| Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 1/51 (2%) 2/54 (4%) 1/53 (2%) 0/53 (0%) 0/53 (0%) 0/53 (0%) 0/53 (0%) |
|POLY-3 RATE (b) | 1/31.44 2/37.71 1/40.51 0/37.32 0/36.61 0/42.13 0/31.91 |
|POLY-3 PERCENT (g) | 3.2% 5.3% 2.5% 0.0% 0.0% 0.0% 0.0% |
|TERMINAL (d) | 0/15 (0%) 2/25 (8%) 0/26 (0%) 0/22 (0%) 0/16 (0%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | 554 727 (T) 328 --- --- --- --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.114N P=0.635 P=0.727N P=0.463N P=0.463N P=0.435N P=0.468N |
|POLY 3 | P=0.080N P=0.563 P=0.702N P=0.466N P=0.470N P=0.442N P=0.497N |
|POLY 1.5 | P=0.088N P=0.545 P=0.719N P=0.472N P=0.477N P=0.458N P=0.491N |
|POLY 6 | P=0.076N P=0.591 P=0.682N P=0.462N P=0.464N P=0.426N P=0.517N |
|LOGISTIC REGRESSION| P=0.101N P=0.566 P=0.690 P=0.515N P=0.502N P=0.537N P=0.494N |
|COCH-ARM / FISHERS | P=0.099N P=0.522 P=0.743N P=0.490N P=0.490N P=0.490N P=0.490N |
|ORDER RESTRICTED | P=0.174N (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Thyroid Gland: C-Cell |
| Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 15/52 (29%) 15/55 (27%) 15/52 (29%) 13/51 (25%) 12/52 (23%) 12/50 (24%) 9/48 (19%) |
|POLY-3 RATE (b) | 15/33.48 15/41.22 15/42.66 13/39.21 12/38.97 12/42.47 9/33.10 |
|POLY-3 PERCENT (g) | 44.8% 36.4% 35.2% 33.2% 30.8% 28.3% 27.2% |
|TERMINAL (d) | 8/15 (53%) 8/25 (32%) 7/26 (27%) 8/22 (36%) 3/16 (19%) 7/23 (30%) 1/7 (14%) |
|FIRST INCIDENCE | 519 524 541 385 454 588 394 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.415N P=0.138N P=0.122N P=0.124N P=0.194N P=0.039N* P=0.430N |
|POLY 3 | P=0.085N P=0.304N P=0.265N P=0.211N P=0.155N P=0.101N P=0.096N |
|POLY 1.5 | P=0.085N P=0.397N P=0.377N P=0.273N P=0.215N P=0.173N P=0.115N |
|POLY 6 | P=0.111N P=0.196N P=0.160N P=0.168N P=0.104N P=0.053N P=0.097N |
|LOGISTIC REGRESSION| P=0.097N P=0.307N P=0.295N P=0.240N P=0.192N P=0.067N P=0.141N |
|COCH-ARM / FISHERS | P=0.105N P=0.513N P=0.586N P=0.436N P=0.328N P=0.371N P=0.172N |
|ORDER RESTRICTED | P=0.129N (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 18
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Thyroid Gland: C-Cell |
| Carcinoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 0/52 (0%) 1/55 (2%) 2/52 (4%) 0/51 (0%) 0/52 (0%) 2/50 (4%) 0/48 (0%) |
|POLY-3 RATE (b) | 0/31.37 1/38.53 2/39.64 0/36.51 0/35.79 2/41.02 0/29.95 |
|POLY-3 PERCENT (g) | 0.0% 2.6% 5.1% 0.0% 0.0% 4.9% 0.0% |
|TERMINAL (d) | 0/15 (0%) 1/25 (4%) 1/26 (4%) 0/22 (0%) 0/16 (0%) 2/23 (9%) 0/7 (0%) |
|FIRST INCIDENCE | --- 727 (T) 709 --- --- 727 (T) --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.561 P=0.602 P=0.368 (e) (e) P=0.336 (e) |
|POLY 3 | P=0.541N P=0.541 P=0.292 (e) (e) P=0.302 (e) |
|POLY 1.5 | P=0.536N P=0.527 P=0.272 (e) (e) P=0.275 (e) |
|POLY 6 | P=0.585N P=0.561 P=0.318 (e) (e) P=0.333 (e) |
|LOGISTIC REGRESSION| P=0.620 P=0.602 P=0.341 (e) (e) P=0.336 (e) |
|COCH-ARM / FISHERS | P=0.539N P=0.514 P=0.248 (e) (e) P=0.238 (e) |
|ORDER RESTRICTED | P=0.438 (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Thyroid Gland: C-Cell |
| Carcinoma or Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 15/52 (29%) 16/55 (29%) 17/52 (33%) 13/51 (25%) 12/52 (23%) 14/50 (28%) 9/48 (19%) |
|POLY-3 RATE (b) | 15/33.48 16/41.22 17/42.73 13/39.21 12/38.97 14/42.47 9/33.10 |
|POLY-3 PERCENT (g) | 44.8% 38.8% 39.8% 33.2% 30.8% 33.0% 27.2% |
|TERMINAL (d) | 8/15 (53%) 9/25 (36%) 8/26 (31%) 8/22 (36%) 3/16 (19%) 9/23 (39%) 1/7 (14%) |
|FIRST INCIDENCE | 519 524 541 385 454 588 394 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.437N P=0.176N P=0.200N P=0.124N P=0.194N P=0.081N P=0.430N |
|POLY 3 | P=0.080N P=0.385N P=0.417N P=0.211N P=0.155N P=0.204N P=0.096N |
|POLY 1.5 | P=0.079N P=0.482N P=0.543N P=0.273N P=0.215N P=0.311N P=0.115N |
|POLY 6 | P=0.107N P=0.261N P=0.278N P=0.168N P=0.104N P=0.120N P=0.097N |
|LOGISTIC REGRESSION| P=0.091N P=0.378N P=0.436N P=0.240N P=0.192N P=0.129N P=0.141N |
|COCH-ARM / FISHERS | P=0.099N P=0.574 P=0.416 P=0.436N P=0.328N P=0.550N P=0.172N |
|ORDER RESTRICTED | P=0.133N (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 19
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Uterus |
| Carcinoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 0/53 (0%) 3/55 (5%) 1/53 (2%) 1/53 (2%) 0/53 (0%) 1/53 (2%) 0/53 (0%) |
|POLY-3 RATE (b) | 0/31.38 3/38.64 1/39.86 1/37.32 0/36.61 1/42.13 0/31.91 |
|POLY-3 PERCENT (g) | 0.0% 7.8% 2.5% 2.7% 0.0% 2.4% 0.0% |
|TERMINAL (d) | 0/15 (0%) 2/25 (8%) 0/26 (0%) 1/22 (5%) 0/16 (0%) 1/23 (4%) 0/7 (0%) |
|FIRST INCIDENCE | --- 700 659 727 (T) --- 727 (T) --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.295N P=0.228 P=0.568 P=0.576 (e) P=0.585 (e) |
|POLY 3 | P=0.170N P=0.159 P=0.547 P=0.534 (e) P=0.558 (e) |
|POLY 1.5 | P=0.178N P=0.144 P=0.531 P=0.525 (e) P=0.538 (e) |
|POLY 6 | P=0.177N P=0.183 P=0.567 P=0.543 (e) P=0.578 (e) |
|LOGISTIC REGRESSION| P=0.225N P=0.206 P=0.535 P=0.576 (e) P=0.585 (e) |
|COCH-ARM / FISHERS | P=0.193N P=0.129 P=0.500 P=0.500 (e) P=0.500 (e) |
|ORDER RESTRICTED | P=0.268N (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Uterus |
| Polyp Stromal |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 4/53 (8%) 5/55 (9%) 7/53 (13%) 3/53 (6%) 8/53 (15%) 5/53 (9%) 4/53 (8%) |
|POLY-3 RATE (b) | 4/31.79 5/39.02 7/40.14 3/37.58 8/37.70 5/42.23 4/32.95 |
|POLY-3 PERCENT (g) | 12.6% 12.8% 17.4% 8.0% 21.2% 11.8% 12.1% |
|TERMINAL (d) | 2/15 (13%) 2/25 (8%) 4/26 (15%) 2/22 (9%) 5/16 (31%) 4/23 (17%) 1/7 (14%) |
|FIRST INCIDENCE | 660 630 652 658 541 700 621 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.238 P=0.479N P=0.591 P=0.328N P=0.250 P=0.491N P=0.440 |
|POLY 3 | P=0.444N P=0.628 P=0.407 P=0.408N P=0.263 P=0.601N P=0.628N |
|POLY 1.5 | P=0.431N P=0.584 P=0.353 P=0.432N P=0.230 P=0.617 P=0.623N |
|POLY 6 | P=0.498N P=0.591N P=0.474 P=0.387N P=0.297 P=0.543N P=0.641 |
|LOGISTIC REGRESSION| P=0.548 P=0.585N P=0.497 P=0.369N P=0.281 P=0.479N P=0.613 |
|COCH-ARM / FISHERS | P=0.441N P=0.524 P=0.263 P=0.500N P=0.179 P=0.500 P=0.642N |
|ORDER RESTRICTED | P=0.712N (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 20
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Uterus |
| Sarcoma Stromal |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 0/53 (0%) 0/55 (0%) 0/53 (0%) 2/53 (4%) 2/53 (4%) 2/53 (4%) 0/53 (0%) |
|POLY-3 RATE (b) | 0/31.38 0/38.53 0/39.60 2/37.58 2/36.68 2/42.18 0/31.91 |
|POLY-3 PERCENT (g) | 0.0% 0.0% 0.0% 5.3% 5.5% 4.7% 0.0% |
|TERMINAL (d) | 0/15 (0%) 0/25 (0%) 0/26 (0%) 1/22 (5%) 1/16 (6%) 1/23 (4%) 0/7 (0%) |
|FIRST INCIDENCE | --- --- --- 658 709 714 --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.300 (e) (e) P=0.322 P=0.277 P=0.361 (e) |
|POLY 3 | P=0.410 (e) (e) P=0.279 P=0.273 P=0.308 (e) |
|POLY 1.5 | P=0.462 (e) (e) P=0.267 P=0.260 P=0.283 (e) |
|POLY 6 | P=0.329 (e) (e) P=0.291 P=0.285 P=0.337 (e) |
|LOGISTIC REGRESSION| P=0.416 (e) (e) P=0.285 P=0.287 P=0.361 (e) |
|COCH-ARM / FISHERS | P=0.507 (e) (e) P=0.248 P=0.248 P=0.248 (e) |
|ORDER RESTRICTED | P=0.297 (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Uterus |
| Sarcoma Stromal or Polyp Stromal |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 4/53 (8%) 5/55 (9%) 7/53 (13%) 5/53 (9%) 10/53 (19%) 7/53 (13%) 4/53 (8%) |
|POLY-3 RATE (b) | 4/31.79 5/39.02 7/40.14 5/37.84 10/37.77 7/42.29 4/32.95 |
|POLY-3 PERCENT (g) | 12.6% 12.8% 17.4% 13.2% 26.5% 16.6% 12.1% |
|TERMINAL (d) | 2/15 (13%) 2/25 (8%) 4/26 (15%) 3/22 (14%) 6/16 (38%) 5/23 (22%) 1/7 (14%) |
|FIRST INCIDENCE | 660 630 652 658 541 700 621 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.158 P=0.479N P=0.591 P=0.571N P=0.123 P=0.575 P=0.440 |
|POLY 3 | P=0.516N P=0.628 P=0.407 P=0.610 P=0.124 P=0.443 P=0.628N |
|POLY 1.5 | P=0.488N P=0.584 P=0.353 P=0.580 P=0.103 P=0.379 P=0.623N |
|POLY 6 | P=0.470 P=0.591N P=0.474 P=0.638 P=0.146 P=0.511 P=0.641 |
|LOGISTIC REGRESSION| P=0.469 P=0.585N P=0.497 P=0.636N P=0.141 P=0.592 P=0.613 |
|COCH-ARM / FISHERS | P=0.487N P=0.524 P=0.263 P=0.500 P=0.075 P=0.263 P=0.642N |
|ORDER RESTRICTED | P=0.505 (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 21
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|Uterus |
| Schwannoma Malignant |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 0/53 (0%) 0/55 (0%) 0/53 (0%) 0/53 (0%) 1/53 (2%) 2/53 (4%) 0/53 (0%) |
|POLY-3 RATE (b) | 0/31.38 0/38.53 0/39.60 0/37.32 1/36.86 2/42.23 0/31.91 |
|POLY-3 PERCENT (g) | 0.0% 0.0% 0.0% 0.0% 2.7% 4.7% 0.0% |
|TERMINAL (d) | 0/15 (0%) 0/25 (0%) 0/26 (0%) 0/22 (0%) 0/16 (0%) 1/23 (4%) 0/7 (0%) |
|FIRST INCIDENCE | --- --- --- --- 658 700 --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.204 (e) (e) (e) P=0.562 P=0.358 (e) |
|POLY 3 | P=0.213 (e) (e) (e) P=0.532 P=0.309 (e) |
|POLY 1.5 | P=0.264 (e) (e) (e) P=0.521 P=0.283 (e) |
|POLY 6 | P=0.151 (e) (e) (e) P=0.543 P=0.337 (e) |
|LOGISTIC REGRESSION| P=0.286 (e) (e) (e) P=0.525 P=0.350 (e) |
|COCH-ARM / FISHERS | P=0.327 (e) (e) (e) P=0.500 P=0.248 (e) |
|ORDER RESTRICTED | P=0.326 (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|All Organs |
| Hemangiosarcoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 2/53 (4%) 0/55 (0%) 0/53 (0%) 1/53 (2%) 0/53 (0%) 0/53 (0%) 0/53 (0%) |
|POLY-3 RATE (b) | 2/31.60 0/38.53 0/39.60 1/37.32 0/36.61 0/42.13 0/31.91 |
|POLY-3 PERCENT (g) | 6.3% 0.0% 0.0% 2.7% 0.0% 0.0% 0.0% |
|TERMINAL (d) | 1/15 (7%) 0/25 (0%) 0/26 (0%) 1/22 (5%) 0/16 (0%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | 671 --- --- 727 (T) --- --- --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.226N P=0.139N P=0.138N P=0.390N P=0.208N P=0.138N P=0.352N |
|POLY 3 | P=0.181N P=0.195N P=0.190N P=0.442N P=0.205N P=0.179N P=0.233N |
|POLY 1.5 | P=0.182N P=0.208N P=0.206N P=0.457N P=0.216N P=0.197N P=0.230N |
|POLY 6 | P=0.198N P=0.177N P=0.174N P=0.429N P=0.196N P=0.163N P=0.251N |
|LOGISTIC REGRESSION| P=0.190N P=0.168N P=0.164N P=0.409N P=0.191N P=0.151N P=0.277N |
|COCH-ARM / FISHERS | P=0.182N P=0.238N P=0.248N P=0.500N P=0.248N P=0.248N P=0.248N |
|ORDER RESTRICTED | P=0.020N* (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 22
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|All Organs |
| Malignant Lymphoma: Histiocytic, Lymphocytic, Mixed, |
| NOS, or Undifferentiated Cell Type |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 0/53 (0%) 2/55 (4%) 0/53 (0%) 2/53 (4%) 1/53 (2%) 1/53 (2%) 2/53 (4%) |
|POLY-3 RATE (b) | 0/31.38 2/40.04 0/39.60 2/37.84 1/37.22 1/42.64 2/32.66 |
|POLY-3 PERCENT (g) | 0.0% 5.0% 0.0% 5.3% 2.7% 2.4% 6.1% |
|TERMINAL (d) | 0/15 (0%) 0/25 (0%) 0/26 (0%) 0/22 (0%) 0/16 (0%) 0/23 (0%) 0/7 (0%) |
|FIRST INCIDENCE | --- 82 --- 658 531 573 611 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.238 P=0.265 (e) P=0.316 P=0.534 P=0.566 P=0.230 |
|POLY 3 | P=0.264 P=0.294 (e) P=0.280 P=0.534 P=0.560 P=0.244 |
|POLY 1.5 | P=0.268 P=0.275 (e) P=0.268 P=0.522 P=0.540 P=0.246 |
|POLY 6 | P=0.264 P=0.324 (e) P=0.295 P=0.546 P=0.581 P=0.232 |
|LOGISTIC REGRESSION| P=0.265 P=0.195 (e) P=0.269 P=0.484 P=0.470 P=0.241 |
|COCH-ARM / FISHERS | P=0.264 P=0.257 (e) P=0.248 P=0.500 P=0.500 P=0.248 |
|ORDER RESTRICTED | P=0.168 (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|All Organs |
| Benign Tumors |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 45/53 (85%) 45/55 (82%) 48/53 (91%) 45/53 (85%) 46/53 (87%) 45/53 (85%) 42/53 (79%) |
|POLY-3 RATE (b) | 45/45.97 45/47.51 48/51.17 45/48.55 46/49.09 45/47.95 42/45.75 |
|POLY-3 PERCENT (g) | 97.9% 94.7% 93.8% 92.7% 93.7% 93.8% 91.8% |
|TERMINAL (d) | 15/15 (100%) 24/25 (96%) 23/26 (89%) 21/22 (96%) 14/16 (88%) 23/23 (100%) 7/7 (100%) |
|FIRST INCIDENCE | 309 356 188 385 247 440 258 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.020 * P=0.016N* P=0.032N* P=0.068N P=0.258N P=0.007N** P=0.258 |
|POLY 3 | P=0.207N P=0.377N P=0.296N P=0.180N P=0.285N P=0.270N P=0.135N |
|POLY 1.5 | P=0.153N P=0.381N P=0.480N P=0.234N P=0.424N P=0.302N P=0.152N |
|POLY 6 | P=0.395N P=0.336N P=0.201N P=0.260N P=0.218N P=0.362N P=0.188N |
|LOGISTIC REGRESSION| P=0.100N P=0.158N P=0.613N P=0.117N P=0.454N P=0.020N* P=0.100N |
|COCH-ARM / FISHERS | P=0.191N P=0.432N P=0.278 P=0.607N P=0.500 P=0.607N P=0.307N |
|ORDER RESTRICTED | P=0.143N (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
Date: 10/01/03 EXPERIMENT: 96007 TEST: 01 Page 23
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 104 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|All Organs |
| Malignant Tumors |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 13/53 (25%) 19/55 (35%) 18/53 (34%) 15/53 (28%) 16/53 (30%) 23/53 (43%) 33/53 (62%) |
|POLY-3 RATE (b) | 13/35.14 19/45.38 18/44.03 15/40.97 16/40.41 23/46.99 33/43.01 |
|POLY-3 PERCENT (g) | 37.0% 41.9% 40.9% 36.6% 39.6% 48.9% 76.7% |
|TERMINAL (d) | 5/15 (33%) 6/25 (24%) 8/26 (31%) 8/22 (36%) 6/16 (38%) 10/23 (44%) 6/7 (86%) |
|FIRST INCIDENCE | 176 82 236 448 40 185 72 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P<0.001 ** P=0.555 P=0.483N P=0.425N P=0.509 P=0.370 P<0.001 ** |
|POLY 3 | P<0.001 ** P=0.414 P=0.451 P=0.583N P=0.502 P=0.192 P<0.001 ** |
|POLY 1.5 | P<0.001 ** P=0.312 P=0.343 P=0.543 P=0.433 P=0.109 P<0.001 ** |
|POLY 6 | P<0.001 ** P=0.561 P=0.592 P=0.520N P=0.584 P=0.323 P<0.001 ** |
|LOGISTIC REGRESSION| P<0.001 ** P=0.162 P=0.244 P=0.500 P=0.385 P=0.049 * P<0.001 ** |
|COCH-ARM / FISHERS | P<0.001 ** P=0.177 P=0.197 P=0.413 P=0.332 P=0.032 * P<0.001 ** |
|ORDER RESTRICTED | P<0.001 ** (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 0 NG/KG 30 NG/KG 100 175 300 550 1000 |
| | NG/KG NG/KG NG/KG NG/KG NG/KG |
|=================================================================================================================================|
| |
|All Organs |
| Malignant and Benign Tumors |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # # # # # # |
|----------- | |
|OVERALL (a) | 49/53 (92%) 51/55 (93%) 51/53 (96%) 47/53 (89%) 49/53 (92%) 50/53 (94%) 49/53 (92%) |
|POLY-3 RATE (b) | 49/49.21 51/52.35 51/52.14 47/49.77 49/50.28 50/51.09 49/50.22 |
|POLY-3 PERCENT (g) | 99.6% 97.4% 97.8% 94.4% 97.5% 97.9% 97.6% |
|TERMINAL (d) | 15/15 (100%) 24/25 (96%) 25/26 (96%) 21/22 (96%) 15/16 (94%) 23/23 (100%) 7/7 (100%) |
|FIRST INCIDENCE | 176 82 188 385 40 185 72 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.006 ** P=0.036N* P=0.021N* P=0.043N* P=0.215N P=0.012N* P=0.175 |
|POLY 3 | P=0.579N P=0.466N P=0.543N P=0.125N P=0.481N P=0.576N P=0.504N |
|POLY 1.5 | P=0.521N P=0.452N P=0.654N P=0.134N P=0.494N P=0.541N P=0.458N |
|POLY 6 | P=0.534 P=0.507N P=0.515N P=0.229N P=0.499N P=0.896N P=0.750N |
|LOGISTIC REGRESSION| P=0.528N P=0.547N P=0.661 P=0.066N P=0.470N P=0.299N P=0.541N |
|COCH-ARM / FISHERS | P=0.542 P=0.621 P=0.339 P=0.371N P=0.642N P=0.500 P=0.642N |
|ORDER RESTRICTED | P=0.279N (e) (e) (e) (e) (e) (e) |
|=================================================================================================================================|
(a) Number of tumor-bearing animals / number of animals examined at site.
(b) Number of tumor-bearing animals / Poly-3 number
(d) Observed incidence at terminal kill.
(f) Beneath the control incidence are the P-values associated with the trend
test. Beneath the dosed group incidence are the P-values corresponding to
pairwise comparisons between the controls and that dosed group. The life
table analysis regards tumors in animals dying prior to terminal kill as
being (directly or indirectly) the cause of death.
Logistic regression is an alternative
method for analyzing the incidence of non-fatal tumors. The Cochran-Armitage
and Fishers exact tests compare directly the overall incidence rates
For all tests a negative trend is indicated by N
(e) Value of Statistic cannot be computed.
(g) Poly-3 adjusted lifetime tumor incidence.
(I) Interim sacrifice
(T) Terminal sacrifice
# Tumor rates based on number of animals necropsied.
* To the right of any statistical result, indicates significance at (P<=0.05).
** To the right of any statistical result, indicates significance at (P<=0.01).